Physician profile
Ambera Dedic
NPI 1003498213
$4,695.36
in general payments reported to CMS, 2019-2025
19 companies · $2,121 in 2025
The $2,121 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $334 · 2022: $715 · 2023: $607 · 2024: $918 · 2025: $2,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,645.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $849.65 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Medtronic, INC. | $804.58 | 2021-2025 | Minimed 780g |
| Mannkind Corporation | $782.70 | 2022-2025 | Afrezza |
| Lilly USA, LLC | $289.41 | 2022-2025 | Mounjaro |
| Beta Bionics, INC. | $245.60 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Dexcom, INC. | $234.88 | 2022-2025 | Dexcom G6 Transmitter |
| Radius Health, INC. | $219.17 | 2025 | Tymlos |
| Abbott Laboratories | $175.51 | 2025 | Freestyle Libre 3 |
| Insulet Corporation | $149.04 | 2025 | Omnipod |
| Sequel Med Tech, LLC | $144.73 | 2025 | Twiist |
| Astrazeneca Pharmaceuticals LP | $143.91 | 2021-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.74 | 2022-2023 | Jardiance |
| Tandem Diabetes Care, INC. | $130.08 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Glaxosmithkline, LLC. | $124.99 | 2023 | Arexvy |
| Horizon Therapeutics Plc | $124.96 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascensia Diabetes Care US INC. | $74.05 | 2024 | |
| Bigfoot Biomedical INC | $26.18 | 2022 | |
| Sanofi-Aventis U.S. LLC | $21.30 | 2022 | |
| Cequr Corporation | $13.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ambera Dedic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.